ZA859286B - Novel treatment - Google Patents

Novel treatment

Info

Publication number
ZA859286B
ZA859286B ZA859286A ZA859286A ZA859286B ZA 859286 B ZA859286 B ZA 859286B ZA 859286 A ZA859286 A ZA 859286A ZA 859286 A ZA859286 A ZA 859286A ZA 859286 B ZA859286 B ZA 859286B
Authority
ZA
South Africa
Prior art keywords
novel treatment
novel
treatment
Prior art date
Application number
ZA859286A
Other languages
English (en)
Inventor
Joergen Buus Lassen
Original Assignee
Ferrosan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan As filed Critical Ferrosan As
Publication of ZA859286B publication Critical patent/ZA859286B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA859286A 1984-12-04 1985-12-04 Novel treatment ZA859286B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848430581A GB8430581D0 (en) 1984-12-04 1984-12-04 Treatment

Publications (1)

Publication Number Publication Date
ZA859286B true ZA859286B (en) 1986-11-26

Family

ID=10570670

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA859286A ZA859286B (en) 1984-12-04 1985-12-04 Novel treatment

Country Status (8)

Country Link
US (1) US4745122A (da)
EP (1) EP0188081B1 (da)
JP (1) JPS61148121A (da)
AU (1) AU580820B2 (da)
DE (1) DE3585607D1 (da)
DK (1) DK158770C (da)
GB (1) GB8430581D0 (da)
ZA (1) ZA859286B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
US5246941A (en) * 1986-12-17 1993-09-21 Glaxo Group Limited Method for the treatment of depression
US4971974A (en) * 1988-06-16 1990-11-20 Neurex Corporation Benzothiophenes as appetite suppressants
KR930702000A (ko) * 1990-11-24 1993-09-08 데이빗 로버츠 노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용
US20020086053A1 (en) * 1993-12-15 2002-07-04 Smithkline Beecham Plc Formulations, tablets of paroxetine and process to prepare them
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
US5900418A (en) * 1997-02-10 1999-05-04 Synapse Pharmaceuticals International, Inc. Method for treatment of obesity
DE29724281U1 (de) * 1997-06-10 2000-08-10 Synthon Bv 4-Phenylpiperidin-Verbindungen
EP1053234A1 (en) * 1998-02-06 2000-11-22 Smithkline Beecham Plc Salts of paroxetine
US20030028027A1 (en) * 1998-04-09 2003-02-06 Smithkline Beecham Plc Paroxetine maleate
GB9808894D0 (en) * 1998-04-25 1998-06-24 Smithkline Beecham Plc Novel compound
GB9814316D0 (en) * 1998-07-02 1998-09-02 Smithkline Beecham Plc Novel compounds
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
EP1102764A1 (en) * 1998-08-08 2001-05-30 Smithkline Beecham Plc Paroxetine salts
GB9826171D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel compounds
GB9826178D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
EP1135383B1 (en) * 1998-11-30 2003-12-03 SmithKline Beecham plc Mixed paroxetine propan-2-ol solvates
GB9826242D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9827431D0 (en) * 1998-12-11 1999-02-03 Smithkline Beecham Plc Novel compound
JP2005514362A (ja) * 2001-11-19 2005-05-19 イーラン ファーマスーティカルズ、インコーポレイテッド ３，４二置換、３，５二置換、及び３，４，５置換ピペリジン及びピペラジン
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
CA2588087A1 (en) * 2004-11-15 2006-05-18 Obe Therapy Biotechnology S.A.S. Methods of reducing body fat
CN101273024A (zh) 2005-07-29 2008-09-24 康瑟特制药公司 新颖苯并[d][1,3]-二氧杂环戊烯衍生物
HUE028064T2 (en) 2007-12-03 2016-11-28 Obe Therapy Biotechnology Inhibitors of enteropeptidase boropeptide and their use in the treatment of diseases associated with obesity, overweight and / or abnormal fat metabolism
TW201212918A (en) * 2010-08-23 2012-04-01 Lundbeck & Co As H Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
CH583730A5 (da) * 1973-09-25 1977-01-14 Wander Ag Dr A
US4442113A (en) * 1981-05-07 1984-04-10 A/S Ferrosan Long-term weight reduction of obese patients using femoxetine

Also Published As

Publication number Publication date
DE3585607D1 (de) 1992-04-16
DK562585A (da) 1986-06-05
DK158770C (da) 1991-01-07
JPH0586763B2 (da) 1993-12-14
DK562585D0 (da) 1985-12-04
EP0188081A2 (en) 1986-07-23
AU5074985A (en) 1986-06-12
EP0188081B1 (en) 1992-03-11
AU580820B2 (en) 1989-02-02
EP0188081A3 (en) 1989-10-11
JPS61148121A (ja) 1986-07-05
US4745122A (en) 1988-05-17
GB8430581D0 (en) 1985-01-09
DK158770B (da) 1990-07-16

Similar Documents

Publication Publication Date Title
ZA859286B (en) Novel treatment
ZA853258B (en) Effluent treatment
GB8419516D0 (en) Treatment
GB8419515D0 (en) Treatment
CS1004884A1 (en) Hydraulicke zarizeni s lanovym pohonem
GB8429670D0 (en) Treatment table
ZA855092B (en) Novel isoindolinyl-alkyl-piperazines
PT84294A (en) Novel treatment
GB8412049D0 (en) Treatment
HK48590A (en) Novel 8alpha-acylaminoergolines
EP0191269A3 (en) Novel homopropargylamines
GB8418430D0 (en) Treatment
ZA86433B (en) Novel treatment
CS125884A1 (en) Budic vibraci s plynulou zmenou vystrednikoveho momentu
ZA852440B (en) Novel substituted-aminohydroxypropoxy-thiadiazoles
CS127885A2 (en) Zpusob vyroby farmaceutickych pripravku s depotnim ucinkem
GB8410680D0 (en) Treatment process
ZA858971B (en) Novel homopropargylamines
GR862004B (en) Novel treatment
GB8427686D0 (en) Treatment
GB8419517D0 (en) Treatment
GB8419514D0 (en) Treatment
GB8406090D0 (en) Treatment
GB8414317D0 (en) Treatment
GB8416278D0 (en) Treatment